A carregar...
Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials
BACKGROUND/AIMS: Numerous reasons have been identified for why U.S.-based principal investigators choose to not continue participating in FDA-regulated trials. However, unexplored are reasons why a substantial number of principal investigators, facing the same challenges, remain engaged in clinical...
Na minha lista:
| Publicado no: | Contemp Clin Trials Commun |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6926102/ https://ncbi.nlm.nih.gov/pubmed/31890985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2019.100502 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|